Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca appoints new global head of product PR

July 15, 2004

AstraZeneca has appointed a new head of global public relations to oversee strategic public relations programmes and all other aspects …

News

Pfizer seizes initiative with US drug discount programme

July 15, 2004

Pfizer will offer drug discounts to the 43 million Americans without health insurance as it seeks to rebuild its image …

News

Embarrassing problem to become marketing battleground

July 15, 2004

News

Lilly’s ‘Cialis Promise’ increases pressure on Viagra

July 15, 2004

The battle for erectile dysfunction market dominance is intensifying in the US with Lilly using consumer-style promotional offers to help …

News

A marriage of inconvenience?

July 14, 2004

Feature

Severe asthma treatment Xolair filed in Europe

July 8, 2004

News

Atacand filed for heart failure in US

July 8, 2004

AstraZeneca has submitted its cardiovascular drug Atacand for an additional US licence to treat heart failure.Atacand (candesartan) is one of …

News

Pfizer’s next blockbuster Lyrica receives European approval

July 8, 2004

Pfizer's potential central nervous system blockbuster Lyrica (pregabalin) has received European marketing approval.The drug has received licences for the treatment …

News

Pfizer UK recruiting for new customer-focused salesforce

July 8, 2004
NHS, Pfizer, salesforce

 Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …

News

Everyday diseases and everyday solutions

July 8, 2004

What is all the fuss about chronic disease management? Go to virtually any NHS conference these days and you will …

Feature

Growing doubts over reliability of HRT trial conclusions

July 6, 2004

Influential publicly-funded trials into HRT which convinced millions of women to stop taking the treatment could be flawed, researchers from …

News

Labour stakes its reputation on NHS Plan part II

July 6, 2004

The government has unveiled a plan for the second half of the 10-year period covered by the NHS Plan, claiming …

News

Unveiled: how to win their attention

July 2, 2004

Sir Arthur Conan Doyle once wrote: "It is a capital mistake to theorise before one has data. Insensibly one begins …

Feature

Takeda to launch ‘radically different’ approach to NHS

July 2, 2004
NHS, Takeda, salesforce

 Takeda UK has unveiled plans for what it calls a ‘radically different’ structure to its sales operations designed to liberate …

News

Second wave of foundation hospitals approved

July 1, 2004

News

Novartis rivals find VALUE in landmark Diovan trial

July 1, 2004

A landmark study comparing Novartis' Diovan with Pfizer's calcium channel blocker Istin has ended with both sides claiming superiority for …

News

Pharma’s reputation continues to slide

July 1, 2004

The reputation of the pharmaceutical industry in the US continues to decline as the public grows increasingly concerned about the …

News

Fast4wD expands clinical trial focus

July 1, 2004

Ogilvy Public Relations Worldwide and Shire Health Group have merged part of their operations to form Fast4wD Ogilvy, a clinical …

News

US parallel trade to be legalised after Republican U-turn

June 29, 2004

Re-importation of cheaper medicines from Canada and other countries into the US looks certain to be legalised after the Bush …

News

Sanofi executives take control of new boardroom

June 24, 2004

The soon to be created Sanofi-Aventis will be dominated by executives from Sanofi-Synthelabo who have pledged to deliver "swift integration" …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025